Indian pharma Glenmark Pharmaceuticals moves to further expand its OTC business in the US by striking a deal with Wockhardt to acquire a portfolio of generic equivalents of brand products.
Financial details of the transaction were not disclosed. Glenmark indicated only that it “continues to expand its OTC portfolio with the acquisition" of Wockhardt's approved abbreviated new drug applications.